Loading…
Chemed Corporation is projected to rise to $644.36 by 2027, a +32% move from its current price of $488.59. CHE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $482.06 | $488.53 | $495.08 | -0.01% |
| Jul 15 | $479.35 | $488.47 | $497.76 | -0.02% |
| Jul 16 | $477.26 | $488.41 | $499.81 | -0.04% |
| Jul 17 | $475.50 | $488.35 | $501.54 | -0.05% |
| Jul 18 | $473.95 | $488.29 | $503.05 | -0.06% |
| Jul 19 | $472.55 | $488.23 | $504.42 | -0.07% |
| Jul 20 | $471.26 | $488.17 | $505.68 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $471.26 | $488.17 | $505.68 | -0.09% |
| Week 2 | $464.02 | $487.74 | $512.68 | -0.17% |
| Week 3 | $458.45 | $487.32 | $518.00 | -0.26% |
| Week 4 | $453.75 | $486.89 | $522.46 | -0.35% |
| Week 5 | $449.60 | $486.47 | $526.37 | -0.43% |
| Week 6 | $445.84 | $486.05 | $529.89 | -0.52% |
| Week 7 | $442.38 | $485.63 | $533.10 | -0.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Chemed Corporation is a healthcare company that delivers hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
The company operates through two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Chemed also provides direct medical services and spiritual and emotional counseling to patients and their families. It was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed Corporation (CHE) currently trades at $480.87 per share, with a market cap of $6.38B and a rank of 1197.
The price outlook is reflected in a year-by-year forecast: 2026 avg $480.87; 2027 avg $633.42; 2028 avg $781.64; 2029 avg $826.46; 2030 avg $941.88, and continuing higher through 2035 ($1,599.36), 2040 ($2,230.73), and 2050 ($4,562.91).
Max values rise along with the averages, with 2030 max $1,284.47, 2034 max $2,068.20, and 2050 max $7,461.92, accompanied by rising ROIs up to 848.9%. The current market position and the long-term forecast together suggest substantial upside potential, albeit with the usual uncertainty of future outcomes.
A major floor 24.6% below — a decisive break under it would weaken the trend.
The nearest floor, 14.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.4% away) — a breakout level to watch.
A major ceiling 10.2% above — clearing it would confirm fresh momentum.
Key CHE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CHE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $484.94 | Buy | $484.87 | Buy |
| MA 10 | $478.41 | Buy | $477.11 | Buy |
| MA 20 | $456.73 | Buy | $464.28 | Buy |
| MA 50 | $441.35 | Buy | $444.55 | Buy |
| MA 100 | $422.13 | Buy | $435.13 | Buy |
| MA 200 | $430.87 | Buy | $442.42 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.92 | Neutral |
| Stoch RSI (14) | 62.37 | Neutral |
| CCI (20) | 97.96 | Neutral |
| Williams %R (14) | -3.44 | Info |
| MACD (12,26,9) | 2.86 | Buy |
| ROC (12) | 10.02 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 96.56 | Sell |
| TRIX (15) | 0.40 | Buy |
| Awesome (5,34) | 37.31 | Buy |
| Ultimate (7,14,28) | 72.16 | Sell |
| Momentum (10) | 35.44 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 488.97 | Sell |
| ADX (14) | 30.22 | Buy |
| ATR (14) | 6.24 | Info |
The 30-day technical picture is bullish, with RSI14 at 70 indicating strong momentum and price action supported by key moving averages.
SMA50 is $430.96 and SMA200 is $429.86, placing the current price above both averages and signaling an upward trend. Support is at $417.21, while resistance stands at $480.87. The most recent 30-day range runs from $439.46 to $526.18, highlighting a broad trading band and the potential for continued upside in the near term.
Annualized volatility is around 30%, underscoring notable price movement and the importance of monitoring near-term risk and momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $368.59 | $488.59 | $631.02 | 0% | Neutral | |
| $527.75 | $644.36 | $822.55 | +32% | Bullish | |
| $652.26 | $811.36 | $1,063.74 | +66% | Bullish | |
| $678.25 | $856.71 | $1,147.12 | +75% | Bullish | |
| $760.27 | $973.28 | $1,326.69 | +99% | Bullish | |
| $836.09 | $1,083.42 | $1,500.15 | +122% | Bullish | |
| $835.27 | $1,094.59 | $1,537.18 | +124% | Bullish | |
| $962.71 | $1,274.87 | $1,813.55 | +161% | Bullish | |
| $1,138.80 | $1,523.06 | $2,192.50 | +212% | Bullish | |
| $1,261.12 | $1,702.62 | $2,478.26 | +248% | Bullish | |
| $1,719.08 | $2,420.71 | $3,692.45 | +395% | Bullish | |
| $3,261.83 | $4,926.09 | $8,054.53 | +908% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $368.59 | $488.59 | $582.43 | +0.00% |
| August 2026 | $413.76 | $484.30 | $579.12 | -0.88% |
| September 2026 | $410.75 | $483.09 | $582.20 | -0.25% |
| October 2026 | $424.44 | $501.25 | $608.07 | +3.76% |
| November 2026 | $432.25 | $512.25 | $624.85 | +2.20% |
| December 2026 | $432.90 | $514.68 | $631.02 | +0.47% |
Click any year to see its month-by-month CHE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Chemed Corporation's 2026 outlook centres on $488.59, within a $368.59 to $631.02 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CHE could reach as high as $822.55, with a base case around $644.36 and support toward $527.75 — roughly +32% from $488.59. Momentum favours further upside here.
Expect CHE to range from $652.26 to $1,063.74 through 2028. The $811.36 average target implies a +66% move from current prices. That is up +26% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CHE price prediction for 2029 points to an average of $856.71 (low $678.25, high $1,147.12) — a potential gain of +75% on today's $488.59. Momentum favours further upside here.
In 2030, CHE is projected to trade between $760.27 and $1,326.69, averaging $973.28 — a potential gain of +99% from today's $488.59. That is up +14% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Chemed Corporation's 2031 outlook centres on $1,083.42, within a $836.09 to $1,500.15 range. That is up +11% on the projected 2030 average. That marks a +122% change versus current levels. Momentum favours further upside here.
By 2032, CHE could reach as high as $1,537.18, with a base case around $1,094.59 and support toward $835.27 — roughly +124% from $488.59. Buyers look set to stay in control over this stretch.
Expect CHE to range from $962.71 to $1,813.55 through 2033. The $1,274.87 average target implies a +161% move from current prices. That is up +16% on the projected 2032 average. Momentum favours further upside here.
The CHE price prediction for 2034 points to an average of $1,523.06 (low $1,138.80, high $2,192.50) — a potential gain of +212% on today's $488.59. Buyers look set to stay in control over this stretch.
In 2035, CHE is projected to trade between $1,261.12 and $2,478.26, averaging $1,702.62 — a potential gain of +248% from today's $488.59. That is up +12% on the projected 2034 average. Momentum favours further upside here.
Chemed Corporation's 2040 outlook centres on $2,420.71, within a $1,719.08 to $3,692.45 range. That is up +42% on the projected 2035 average. That marks a +395% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CHE could reach as high as $8,054.53, with a base case around $4,926.09 and support toward $3,261.83 — roughly +908% from $488.59. Momentum favours further upside here.
Investing $1,000 in CHE today (≈ 2.046706 CHE) could be worth
$10,082.25
+$9,082.25 (+908%) by 2050 · US Dollar
Based on the average projected CHE price of $4,926.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CHEwould be worth at today's price.
$1,000 invested in CHE on Jul 10, 2025 (≈ 2.147397 CHE) would be worth
$1,049.2
+$49.2 (+4.9%) today · 1.05× · US Dollar
Based on a CHE entry price of $465.68 vs. today's $488.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $489.66 | $997.81 | -0.2% |
| 1 month ago | $434.42 | $1,124.69 | +12.5% |
| 3 months ago | $385.84 | $1,266.3 | +26.6% |
| 6 months ago | $446.15 | $1,095.12 | +9.5% |
| 1 year ago | $465.68 | $1,049.2 | +4.9% |
| All time (5.0y) ago | $468.84 | $1,042.13 | +4.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CHE forecast.
Our base-case forecast reaches $980.00 around 2031.
Implied market cap at $980.00: $13.01B
The multi-year outlook shows meaningful upside across the horizon. By 2027 the average price is forecast at $633.42 with a 31.7% ROI, followed by continued expansion to 2028 at $781.64 (62.5% ROI) and 2029 at $826.46 (71.9% ROI).
In 2030 the forecast annual average is $941.88 with a 95.9% ROI and bullish sentiment. The path continues higher through 2031 ($1,031.13 avg, 114.4% ROI), 2032 ($1,036.85, 115.6%), and 2033 ($1,215.49, 152.8%). By 2034 the average rises to $1,436.26 and max to $2,068.20 (198.7% ROI), and by 2035 the average is $1,599.36 with a max of $2,328.65 (232.6% ROI).
The forecast extends to 2040, with an average of $2,230.73 and a max of $3,403.43 (363.9% ROI), and to 2050, with an average of $4,562.91 and a max of $7,461.92 (848.9% ROI), all with bullish sentiment. These figures illustrate a rising-long horizon trajectory, but they remain estimates and are not guarantees; actual results may vary with market conditions and company performance.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $941.88 per share, with a min of $735.49 and a max of $1,284.47. The expected ROI is 95.9%, and sentiment is BULLISH.
The 2026 forecast is neutral with an average price of $480.87 and a max of $623.79. From 2027 onward the outlook is BULLISH, with rising averages and ROIs reaching up to 848.9% by 2050, indicating substantial long-term upside alongside inherent uncertainty.
Yes. The forecast shows a max of $2,068.20 in 2034, followed by higher maxes (e.g., $2,328.65 in 2035, $3,403.43 in 2040, and $7,461.92 in 2050), implying the potential to exceed $2,000 in the medium term.
The 30-day picture is bullish with RSI14 at 70. The SMA50 is $430.96 and the SMA200 is $429.86, with support at $417.21 and resistance at $480.87. The 30-day range is $439.46 to $526.18.
The long-term forecast shows an average of $4,562.91 and a max of $7,461.92 by 2050, with an ROI of 848.9% and a bullish sentiment, indicating substantial upside over the coming decades.
Chemed Corporation Community Discussion
0Share your Chemed Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.